Use of SGLT2 Inhibitors vs GLP-1 RAs and Anemia in Patients With Diabetes and CKD
JC Hu, SC Shao, D Hsiang-Te Tsai… - JAMA network …, 2024 - jamanetwork.com
Importance Sodium-glucose cotransporter 2 (SGLT2) inhibitors are associated with lower
anemia risk, based on findings from post hoc analyses of the CREDENCE and DAPA-CKD …
anemia risk, based on findings from post hoc analyses of the CREDENCE and DAPA-CKD …